Burcu Öztürk Şahin

Burcu Öztürk Şahin

Auto-generated profile, based on publicly available information

Burcu Öztürk Şahin

Department of Pulmonary Medicine, University of Health Sciences Gulhane School of Medicine Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Echocardiography
Verified
Journal Article
Closed access
PDF file
GGGül Gürsel
Gül Gürsel
UÖUğur Özdemir
Uğur Özdemir
TGTuba Güney
Tuba Güney
NKNur Karaarslan
Nur Karaarslan
OTOmer Tekin
Omer Tekin
BÖBurcu Öztürk
Burcu Öztürk

5 April 2022 in Balkan Medical Journal
Verified
Journal Article
Open access
OTOya Baydar Toprak
Oya Baydar Toprak
ŞÖŞennur Özen
Şennur Özen
BŞBurcu Öztürk Şahin
Burcu Öztürk Şahin
NKNurdan Kokturk
Nurdan Kokturk
MKMehmet Tevfik Kitapçı
Mehmet Tevfik Kitapçı
Background: As vaccination against coronavirus disase-19 (COVID-19) evolves, hesitancy has become a problematic issue that has gradually spread worldwide. The main reason for vaccine hesitancy is uncertainties about vaccine side effects. Aims: To evaluate the safety of an inactivated COVID-19 vaccine, CoronaVac, and determine the risk factors of emergence of side effects. Study Design: Cross-sectional study. e lea-ids: An online questionnaire was administered via the internet to healthcare workers who received one or two doses of CoronaVac. The online survey consisted of three sections detailing sociodemographic data, COVID-19 history; and post-vaccine side effects. Side effects that occurred in the period starting from immediately after the first vaccination to the end of the 14th day after the second vaccination were recorded. Results: A total of 1628 healthcare workers responded to the online survey. Of these, 24.3% had a side effect either after the first or second dose of CoronaVac. Redness and/or pain at the inoculation site, headache, muscle and joint pains, palpitations, and dizziness were the most common side effects. Female sex, age <50 years, and thyroid disorder in the pre-vaccine period were found to be risk factors for the emergence of side effects. Blood pressure control could not be achieved in 2.2% of participants despite medication use, and permanent medication was needed in 2.5% of participants for blood pressure control. Conclusion: Almost a quarter of healthcare workers have at least one side effect after the first or second dose of CoronaVac. Female gender. age <50 years, and thyroid disorder appear to be risk factors for the occurrence of side effects.

1 December 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
ABAyse Baha
Ayse Baha
CBCaner Baysan
Caner Baysan
SNSibel Nayci
Sibel Nayci
EOEylem Ozgur
Eylem Ozgur
TKTugce Karamustafalioglu
Tugce Karamustafalioglu
OHOsman Hilmioglu
Osman Hilmioglu
Objective: The Rome classification was introduced to assess the severity of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) based on easily measurable variables. However, its validation for global use has not yet reached a sufficient level. This study aims to evaluate the validity of the Rome criteria in determining the severity and prognosis of COPD AE in Turkey. Methods: This multicenter study, conducted for the first time in Turkey and for the fourth time worldwide, included 750 patients diagnosed with AE-COPD who presented to emergency departments and outpatient clinics. According to the Rome criteria, patients were classified into three groups: mild, moderate, and severe AE-COPD. Results: The study included 99 (13.2%) patients in the mild, 479 (63.9%) in the moderate, and 172 (22.9%) in the severe group. Emergency visits, hospitalizations, and ICU admissions in the past year were more frequent in the moderate and severe groups (p < 0.001 for all comparisons). Regarding outcomes of emergency or outpatient visits, most mild exacerbation cases were discharged (p < 0.001), while most moderate and severe exacerbations required hospitalization (p < 0.001). Compared to the moderate group, the severe exacerbation group had a higher risk of ICU admission (p < 0.001), NIV (p < 0.001), IMV (p < 0.001), in-hospital mortality (p < 0.001), and 30-day mortality (p = 0.015). No significant differences were found in 90-day mortality or 30 and 90-day readmission rates (p = 0.258, p = 0.712, p = 0.681, respectively). Survival analysis revealed no significant difference between the moderate and severe groups (p = 0.764). Conclusion: The findings suggest that the Rome criteria can be successfully used to assess exacerbation severity in AE-COPD patients presenting to secondary and tertiary care hospitals in Turkey.

29 November 2024 in Medicine
Verified
Journal Article
Open access
OTOya Baydar Toprak
Oya Baydar Toprak
MPMehmet Polatli
Mehmet Polatli
ABAyşe Baha
Ayşe Baha
NKNurdan Kokturk
Nurdan Kokturk
DYDilek Yapar
Dilek Yapar
BMBurak Mete
Burak Mete
Chronic obstructive pulmonary disease (COPD) frequently results in hospital readmission and contributes to increased morbidity and mortality. This multicenter prospective study aimed to identify factors that increase the risk of readmission within 30 to 90 days of severe COPD exacerbation. A total of 415 patients admitted to the emergency department (ED) or general pulmonology ward after discharge due to severe exacerbations from 13 tertiary centers in Turkey were included. Of the participants, 346 (83.4%) were male and 69 (16.6%) were female, with an average age of 69.0 ± 9.1 years. Readmissions within 30 and 90 days after the initial hospitalization occurred in 176 (42.4%) and 191 (46%) patients, respectively. Prospective data collection focused on exacerbation severity, disease severity, and the utility of initial admissions. Factors for 30 to 90 day readmission were analyzed using univariate and multivariate regression models. A 30-day readmission correlated significantly with Hospital Anxiety Depression Scale scores above 16 [odds ratio [OR] 95% confidence intervals [CI]: 1.9 (1.1–3.6); P = .042], severe exacerbation history in the previous year [OR 95% CI: 1.7 (1.1–2.9); P = .038], hospital-acquired pneumonia [OR 95% CI: 1.9 (1–4.1); P = .049)], and frequent antibiotic use in the previous year [OR 95% CI: 1.8 (1.2–2.7); P = .007]. Risk factors for 90-day readmissions included: Grades 3 to 4 tricuspid regurgitation [OR 95% CI: 2.2 (1.1–4.4); P = .024], 2 or more moderate COPD exacerbations [OR 95% CI: 1.9 (1.2–3.1); P = .010], severe exacerbation history in the previous year [OR 95% CI: 2.5 (1.5–4.2); P = .001], immunosuppression [OR 95% CI: 2.7 (1.2–5.7); P = .013], frequent antibiotic use the previous year [OR 95% CI: 1.5 (1–2.4); P = .048], hospitalization via the ED [OR 95% CI: 1.6 (1.1–2.6); P = .028]. To mitigate complications and readmissions, patients with a history of frequent severe COPD exacerbations, high anxiety and depression scores, frequent antibiotic requirements, immunosuppression, tricuspid regurgitation, hospital-acquired pneumonia, and those admitted to the ED should be prioritized for remote monitoring after initial discharge.

22 September 2023 in Tuberk Toraks
Verified
Journal Article
Open access
YYYeşim Yıldız
Yeşim Yıldız
BŞBurcu Öztürk Şahin
Burcu Öztürk Şahin
MTMert Can Taşdemir
Mert Can Taşdemir
ŞDŞerife Demir
Şerife Demir
BÇBeyza Çiftci
Beyza Çiftci
IOI.Kivilcim Oguzulgen
I.Kivilcim Oguzulgen
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.

1 January 2026 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
FAFatma Arslan
Fatma Arslan
EŞElif Şen
Elif Şen
BŞBurak Şirin
Burak Şirin
NKNurdan Kokturk
Nurdan Kokturk
GUGaye Ulubay
Gaye Ulubay
NENihal Ensen
Nihal Ensen
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is frequently underdiagnosed due to limited use and suboptimal quality of spirometry. Methods: This multicenter, prospective observational study aimed to assess the quality of spirometry tests in COPD patients across six tertiary care centers in Turkey. A total of 560 spirometry tests were independently evaluated by two pulmonologists, and inter-rater reliability was analyzed using Cohen’s Kappa. Results: The study included 124 women and 436 men, with a mean age of 65.9± 10.2 years. Spirometry patterns were interpreted as obstructive in 79.1% of tests, restrictive in 5.7%, mixed in 2.7%, normal in 6.7%, inconclusive in 5.5%, and as upper airway obstruction in 0.18% of cases (K=0.890). Routine post-bronchodilator testing was performed in 87.14% of the cases, while 12.85% were post-reversibility tests. Graphical data included volume-time curves (88.5%), flow-volume loops (99.6%), and inspiratory limbs (98.7%). Reference values were predominantly based on ECSC (86.4%), followed by GLI (8.9%) and NHANES (0.25%). Mean spirometric values included FEV1 (% predicted) 57.2%, FVC (% predicted) 72.7%, and FEV1/FVC 61.9%. Cough in the first second of FVC was observed in 17 (3%) (K=0.677), variable or insufficient effort 13.4% (K=0.563), mouth leak 1.8% (K=0.305), mouthpiece obstruction 0.5% (K=0.332), rapid expiration 1.8% (K=0.354), increased concavity 83% (K=0.683), and small airway obstruction 87% (K=0.709) were reported by interpreters. Conclusion: Spirometry reports frequently lack key information such as preliminary diagnoses, test indication, technician, and device details. ECSC is the most commonly used reference. Rates of inconclusive and erroneous tests—due to variable or insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration—are low.